For many, medications like GLP-1 receptor agonists have provided a lifeline, helping to curb appetite, enhance satiety, and facilitate significant weight loss
doi: 10.1007/s00384-014-2030-8
Medicare Obesity Coverage Expansion (Regulatory): The Centers for Medicare & Medicaid Services (CMS) announced that beginning in April 2026, Medicare will cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities via the BALANCE Model and Section 402 demonstrations, marking a reversal of the long-standing statutory ban on weight-loss drug coverage
Over the study period, prescriptions for AOM liraglutide remained relatively stable and low, averaging 0.9 +/- 0.6 prescriptions per 100,000 adolescents
Applicable Procedure Codes: 0744T, 36465, 36466, 36468, 36470, 36471, 36473, 36474, 36475, 36476, 36478, 36479, 36482, 36483, 37700, 37718, 37722, 37735, 37780, 37785
En revanche, les autres estrases hydrolysent uniquement les substrats hydrosolubles chane courte